Related references
Note: Only part of the references are listed.Past, presence, and future of allergen immunotherapy vaccines
Yulia Dorofeeva et al.
ALLERGY (2021)
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Jean Bousquet et al.
ALLERGY (2021)
COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients
Oliver Pfaar et al.
ALLERGY (2021)
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper
Oliver Pfaar et al.
ALLERGY (2021)
Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response
Korneliusz Golebski et al.
IMMUNITY (2021)
Allergy/Immunology Trainee Experiences During the COVID-19 Pandemic: AAAAI Work Group Report of the Fellows-in-Training Committee
Basil M. Kahwash et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Allergen immunotherapy: The growing role of observational and randomized trial Real-World Evidence
Giovanni Paoletti et al.
ALLERGY (2021)
COVID-19 pandemic and allergen immunotherapy-an EAACI survey
Oliver Pfaar et al.
ALLERGY (2021)
Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis A Randomized, Double-Blind, Placebo-controlled Clinical Trial
Mohamed H. Shamji et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art
David C. Wraith et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy
Hanisah Sharif et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Decrease in CD38+ TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses
Sonia Luce et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
Oliver Pfaar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience
Erika Jensen-Jarolim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Oliver Pfaar et al.
ALLERGY (2021)
Anti-IgE: A treatment option in allergic rhinitis?
O. Pfaar et al.
ALLERGOLOGIE (2021)
Use of biologics in allergen immunotherapy
W. Pfuetzner et al.
ALLERGOLOGIE (2021)
Induction of IgG2 and IgG4 B-cell memory following sublingual immunotherapy for ryegrass pollen allergy
Jorn J. Heeringa et al.
ALLERGY (2020)
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
Erika Jensen-Jarolim et al.
ALLERGY (2020)
Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma
Marek Jutel et al.
ALLERGY (2020)
Cost-effectiveness of grass pollen allergen immunotherapy in adults
Danilo Di Bona et al.
ALLERGY (2020)
Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?
Phornsiri Pechsrichuang et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Highlights of Novel Vaccination Strategies in updates Allergen Immunotherapy
Zsolt Istvan Komlosi et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)
Algorithms in allergen immunotherapy in allergic rhinoconjunctivitis
Oliver Pfaar et al.
ALLERGY (2020)
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Ludger Klimek et al.
ALLERGY (2020)
Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy
Azahara Rodriguez-Dominguez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic
Marcus S. Shaker et al.
Journal of Allergy and Clinical Immunology-In Practice (2020)
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research
Litty Johnson et al.
VACCINES (2020)
Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
Inna Tulaeva et al.
FRONTIERS IN IMMUNOLOGY (2020)
Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing
Jean Bousquet et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2020)
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019
V. Mahler et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2020)
Allergy immunotherapy: Future directions for the 2020s
Harold S. Nelson
ALLERGY AND ASTHMA PROCEEDINGS (2020)
New guidance on the regulation of allergen products: key aspects and outcomes
Andreas Bonertz et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Allergic rhinitis
Jean Bousquet et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
A. Bedard et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2020)
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
Max E. Kirtland et al.
FRONTIERS IN IMMUNOLOGY (2020)
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic
Fabio Cardinale et al.
ITALIAN JOURNAL OF PEDIATRICS (2020)
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Ulrich Wahn et al.
ALLERGY (2019)
Role of IL-35 in sublingual allergen immunotherapy
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
Jean Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial
David M. Fleischer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
J. Bousquet et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2019)
2019 ARIA Care pathways for allergen immunotherapy
Jean Bousquet et al.
ALLERGY (2019)
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
Ioana Agache et al.
ALLERGY (2019)
Manufacturing and quality assessment of allergenic extracts for immunotherapy: state of the art
Andreas Bonertz et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Perspectives in allergen immunotherapy: 2019 and beyond
Oliver Pfaar et al.
ALLERGY (2019)
Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy
Tadech Boonpiyathad et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma
Oliver Pfaar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial
Tilo Biedermann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
EAACI guidelines on allergen immunotherapy: Executive statement
A. Muraro et al.
ALLERGY (2018)
Synchronous immune alterations mirror clinical response during allergen immunotherapy
Amedee Renand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
Erkka Valovirta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
J. M. Orengo et al.
NATURE COMMUNICATIONS (2018)
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
G. J. Sturm et al.
ALLERGY (2018)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
G. Roberts et al.
ALLERGY (2018)
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
G. B. Pajno et al.
ALLERGY (2018)
Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery
Karin Stenberg et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2018)
National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-II
D. E. S. Larenas-Linnemann et al.
ALLERGY (2018)
Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis
S. Zielen et al.
ALLERGY (2018)
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products
A. Bonertz et al.
ALLERGY (2018)
Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview
M. Asaria et al.
ALLERGY (2018)
Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity A Randomized Clinical Trial
Hugh A. Sampson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis The GRASS Randomized Clinical Trial
Guy W. Scadding et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis
Kimihiro Okubo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
EAACI guidelines on allergen immunotherapy: Prevention of allergy
Susanne Halken et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2017)
Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study
Yan Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis
S. Dhami et al.
ALLERGY (2017)
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis
S. Dhami et al.
ALLERGY (2017)
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
M. H. Shamji et al.
ALLERGY (2017)
T follicular helper (Tfh) cells in normal immune responses and in allergic disorders
G. Varricchi et al.
ALLERGY (2016)
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma A Randomized Clinical Trial
J. Christian Virchow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Allergen immunotherapy: No evidence of infectious risk
Diana S. Balekian et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy
Claire Gueguen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
Hendrik Nolte et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
Jean Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial
Pascal Demoly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Clinical contraindications to allergen immunotherapy: an EAACI position paper
C. Pitsios et al.
ALLERGY (2015)
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy
Satya D. Narisety et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Administration of a probiotic with peanut oral immunotherapy: A randomized trial
Mimi L. K. Tang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Basophil expression of diamine oxidase: A novel biomarker of allergen immunotherapy response
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Oral Immunotherapy for Egg Allergy: A Double-Blind Placebo-Controlled Study, with Postdesensitization Follow-Up
Lucia Caminiti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
Alain Didier et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2015)
Doing transformational change in the English NHS in the context of big bang redisorganisation Findings from the North East transformation system
David J. Hunter et al.
JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT (2015)
Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review
T. Zuberbier et al.
ALLERGY (2014)
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
O. Pfaar et al.
ALLERGY (2014)
Safety and tolerability of a short ragweed sublingual immunotherapy tablet
Hendrik Nolte et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Seasonal increases in peripheral innatelymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy
Mongkol Lao-Araya et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis
Peter S. Creticos et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
Margitta Worm et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2014)
A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis
A. Meadows et al.
HEALTH TECHNOLOGY ASSESSMENT (2013)
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
TH2, allergy and group 2 innate lymphoid cells
Paula Licona-Limon et al.
NATURE IMMUNOLOGY (2013)
Allergen Immunotherapy and Tolerance
Tomokazu Matsuoka et al.
ALLERGOLOGY INTERNATIONAL (2013)
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy
Erik Wambre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Oral Immunotherapy for Treatment of Egg Allergy in Children
A. Wesley Burks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Affordability as a discursive accomplishment in a changing National Health Service
Jill Russell et al.
SOCIAL SCIENCE & MEDICINE (2012)
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA(2)LEN) article
Philippe J. Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
Michael Blaiss et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization
Edwin H. Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
Jenny M. Mjosberg et al.
NATURE IMMUNOLOGY (2011)
Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study
Giovanni Battista Pajno et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy
N. Lalek et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
Marc Massanari et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract
M. Fernandez-Rivas et al.
ALLERGY (2009)
House Dust Mite Sublingual Immunotherapy The Role for Transforming Growth Factor-β and Functional Regulatory T Cells
Robyn E. O'Hehir et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The Principle of Homologous Groups in Regulatory Affairs of Allergen Products A Proposal
A. R. Lorenz et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
Albrecht Bufe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
Ulrich Wahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Specific oral tolerance induction in children with very severe cow's milk-induced reactions
Giorgio Longo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity
James N. Francis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
Alain Didier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation
Barbara Bohle et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-β expression
Charles Pilette et al.
JOURNAL OF IMMUNOLOGY (2007)
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
G. W. Canonica et al.
ALLERGY (2007)
The IgE-facilitated allergen binding (FAB) assay:: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses
Mohamed H. Shamji et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
Ronald Dahl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis
AJ Frew et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Sublingual immunotherapy for hazelnut food allergy:: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract
E Enrique et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity
KT Nouri-Aria et al.
JOURNAL OF IMMUNOLOGY (2004)
IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
M Jutel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)
C Möller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Allergic rhinitis and its impact on asthma
J Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
IL-4 production by human basophils found in the lung following segmental allergen challenge
JT Schroeder et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
